[Usefulness of 18F-FDG-PET in breast cancer imaging].
作者信息
Tayama Kohsuke, Toh Uhi, Fujii Teruhiko, Shirouzu Kazuo, Kaida Yuto
机构信息
Department of Surgery, Kurume University School of Medicine.
出版信息
Nihon Rinsho. 2007 Jun 28;65 Suppl 6:373-8.
PMID:17679209
Abstract
摘要
相似文献
1
[Usefulness of 18F-FDG-PET in breast cancer imaging].
Nihon Rinsho. 2007 Jun 28;65 Suppl 6:373-8.
2
Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
Radiol Clin North Am. 2007 Jul;45(4):659-67, vi. doi: 10.1016/j.rcl.2007.05.005.
3
[Early prediction of response to primary chemotherapy by sequential FDG -PET in patients with advanced breast cancer].
Nihon Rinsho. 2007 Jun 28;65 Suppl 6:385-8.
4
Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
PLoS One. 2014 Dec 17;9(12):e115127. doi: 10.1371/journal.pone.0115127. eCollection 2014.
5
[FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
Nihon Rinsho. 2007 Jun 28;65 Suppl 6:379-84.
6
F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Invest Radiol. 2003 May;38(5):250-6. doi: 10.1097/01.RLI.0000063983.86229.f2.
7
Oncological applications of FDG PET imaging.
J Nucl Med. 1999 Oct;40(10):1706-15.
8
PET imaging in breast cancer.
Q J Nucl Med. 2001 Sep;45(3):245-56.
9
PET/CT Imaging for Monitoring Recurrence and Evaluating Response to Treatment in Breast Cancer.
Adv Clin Exp Med. 2016 Mar-Apr;25(2):377-82. doi: 10.17219/acem/29853.
10
18F-FDG PET in detecting primary breast cancer.
J Nucl Med. 2007 Oct;48(10):1751; author reply 1752. doi: 10.2967/jnumed.107.043265.
Zotero 插件